HCI
OACC

Harraden Circle Investments’s Oaktree Acquisition Corp III Life Sciences OACC Stock Holding History

Harraden Circle Investments’s Portfolio OACC Stock Details OACC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-502,500
Closed -$5.14M – 137
2025
Q1 		$5.14M Buy
+502,500
New +$5.04M 2.34% 16

Other funds holding OACC

AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
LIP
Lighthouse Investment Partners Palm Beach Gardens, Florida $3.66B AUM 32.08% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
BGIM
Boussard & Gavaudan Investment Management London, United Kingdom $1.06B AUM 4.58% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
DAM
Decagon Asset Management London, United Kingdom $525M AUM 50.51% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Harraden Circle Investments's OACC Position: Q2 2025 in Review

Harraden Circle Investments sold out of Oaktree Acquisition Corp III Life Sciences (OACC) in Q2 2025, closing a stake of 502,500 shares — an estimated $5.14M sold.

Harraden Circle Investments first reported a position in OACC in Q1 2025 and held it in 1 quarter. The position peaked at $5.14M in Q1 2025. 47 funds tracked by Wall St. Rank hold OACC as of Q2 2025.

  • Harraden Circle Investments reported no remaining Oaktree Acquisition Corp III Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Harraden Circle Investments sold 502,500 Oaktree Acquisition Corp III Life Sciences shares in Q2 2025, an estimated $5.14M.
  • Harraden Circle Investments first reported a position in Oaktree Acquisition Corp III Life Sciences in Q1 2025 and held it in 1 quarter.
  • Harraden Circle Investments's Oaktree Acquisition Corp III Life Sciences position peaked at $5.14M in Q1 2025.
  • 47 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences as of Q2 2025.

Based on Harraden Circle Investments's 13F filing for Q2 2025, filed 14 Aug 2025.